Compounds > tibolone
Page last updated: 2024-08-16

tibolone and medroxyprogesterone

tibolone has been researched along with medroxyprogesterone in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.25)18.2507
2000's14 (87.50)29.6817
2010's1 (6.25)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balasch, J; Casals, E; Castelo-Branco, C; Figueras, F; Sanjuan, A; Vanrell, JA; Vicente, JJ1
Bianchi, S; Fedele, L; Raffaelli, R; Zanconato, G1
Alper, T; Cetinkaya, MB; Kökçü, A; Malatyalioğlu, E; Yanik, F1
Anthony, MS; Clarkson, TB; Wagner, JD1
Bak, AA; Banga, JD; Bots, ML; de Kleijn, MJ; Engelen, S; Grobbee, DE; Planellas, J; van der Schouw, YT; Wilmink, HW1
Berglund, L; Christau, S; Hänggi, W; Helmond, F; Huber, J; Palacios, S; Sathanandan, SM1
Aragón Meras, E; Elizondo Alanís, LJ; Gaxiola Cueto, MA; Zayas Jaime, FJ1
Battaglia, C; de Aloysio, D; Mancini, F; Penacchioni, P; Persico, N; Regnani, G; Volpe, A1
Alexandrou, A; Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Liakakos, T; Panoulis, C; Papadias, C; Sarandakou, A1
Aytan, H; Kelekci, S; Mollamahmutoglu, L; Oguz, S; Sargin, A; Tapisiz, OL1
Ciaponi, M; Fini, M; Gambacciani, M; Genazzani, AR; Mercuro, G; Monteleone, P; Rosano, GM; Silvestri, A; Vitale, C1
Bozkaya, H; Okumuş, B; Osmanağaoğlu, MA; Osmanağaoğlu, S; Osmanağaoğlu, T1
Christodoulakos, GE; Creatsas, GC; Fexi, P; Koundi, KL; Lambrinoudaki, IV; Sakkas, PN; Soldatos, CR; Spyropoulou, A; Zervas, IM1
Blok, LJ; Boers-Sijmons, B; Burger, CW; den Bakker, MA; Hanifi-Moghaddam, P; Klaassens, AH; Kloosterboer, HJ; Ott, MC; Shipley, GL; van Wijk, FH; Verheul, HA1
Cline, JM; Hofling, M; Ma, L; Masironi, B; Sahlin, L; von Schoultz, B1
Brito, LG; Candido Dos Reis, FJ; Ferriani, RA; Martins, WP; Moroni, RM; Nastri, CO; Vieira, CS1

Reviews

1 review(s) available for tibolone and medroxyprogesterone

ArticleYear
Add-back therapy with GnRH analogues for uterine fibroids.
    The Cochrane database of systematic reviews, 2015, Mar-20, Issue:3

    Topics: Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Estriol; Female; Gonadotropin-Releasing Hormone; Humans; Isoflavones; Leiomyoma; Medroxyprogesterone; Norpregnenes; Quality of Life; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Uterine Neoplasms

2015

Trials

12 trial(s) available for tibolone and medroxyprogesterone

ArticleYear
Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AI and B.
    Menopause (New York, N.Y.), 1999,Summer, Volume: 6, Issue:2

    Topics: Anabolic Agents; Analysis of Variance; Apolipoproteins A; Apolipoproteins B; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipid Metabolism; Medroxyprogesterone; Middle Aged; Norpregnenes; Postmenopause; Progesterone Congeners; Prospective Studies; Reference Values; Time Factors; Treatment Outcome

1999
A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas.
    European journal of obstetrics, gynecology, and reproductive biology, 2000, Volume: 88, Issue:1

    Topics: Administration, Cutaneous; Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone; Middle Aged; Norpregnenes; Progesterone Congeners; Treatment Outcome; Uterine Neoplasms

2000
The comparison of effects of tibolone and conjugated estrogen-medroxyprogesterone acetate therapy on sexual performance in postmenopausal women.
    Maturitas, 2000, Jul-31, Volume: 36, Issue:1

    Topics: Anabolic Agents; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Middle Aged; Norpregnenes; Postmenopause; Progesterone Congeners; Prospective Studies; Sexuality; Single-Blind Method

2000
Hormone replacement therapy and endothelial function. Results of a randomized controlled trial in healthy postmenopausal women.
    Atherosclerosis, 2001, Volume: 159, Issue:2

    Topics: Aged; Cardiovascular Diseases; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Endothelium, Vascular; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Middle Aged; Norpregnenes; Postmenopause; Reference Values

2001
Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women.
    BJOG : an international journal of obstetrics and gynaecology, 2002, Volume: 109, Issue:8

    Topics: Drug Combinations; Estrogen Receptor Modulators; Estrogens; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Middle Aged; Norpregnenes; Quality of Life; Uterine Hemorrhage

2002
[Effects of the hormone replacement therapy on cardiovascular system, bone mass and memory in climacteric patients].
    Ginecologia y obstetricia de Mexico, 2004, Volume: 72, Issue:1

    Topics: Adult; Aged; Bone Density; Cardiovascular System; Cholesterol; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Memory; Memory Disorders; Middle Aged; Norpregnenes; Postmenopause; Treatment Outcome

2004
Tibolone, oral or transdermal hormone replacement and colour Doppler analysis: a prospective, randomised pilot study.
    Maturitas, 2004, Aug-20, Volume: 48, Issue:4

    Topics: Administration, Cutaneous; Administration, Oral; Androgen Antagonists; Blood Flow Velocity; Carotid Artery, Internal; Estrogens; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Middle Aged; Norpregnenes; Ophthalmic Artery; Pilot Projects; Postmenopause; Prospective Studies; Thromboxanes; Time Factors; Ultrasonography, Doppler, Color; Uterus

2004
Effect of hormone therapy, tibolone and raloxifene on circulating vascular endothelial growth factor in Greek postmenopausal women.
    European journal of endocrinology, 2004, Volume: 151, Issue:2

    Topics: Estrogen Antagonists; Estrogen Replacement Therapy; Estrogens; Female; Greece; Humans; Medroxyprogesterone; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Vascular Endothelial Growth Factor A

2004
The role of hormone replacement therapy in endometrial polyp formation.
    Maturitas, 2005, Mar-14, Volume: 50, Issue:3

    Topics: Adult; Contraceptives, Oral, Synthetic; Double-Blind Method; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hysteroscopy; Medroxyprogesterone; Menopause; Middle Aged; Norethindrone; Norpregnenes; Obesity; Polyps; Prospective Studies; Recurrence; Regression Analysis

2005
Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.
    Maturitas, 2005, Apr-11, Volume: 50, Issue:4

    Topics: Brachial Artery; Cardiovascular Diseases; Cross-Over Studies; Dehydroepiandrosterone; Double-Blind Method; Endothelin-1; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Forearm; Humans; Medroxyprogesterone; Middle Aged; Nitrates; Nitrites; Nitroglycerin; Norpregnenes; Postmenopause; Pulsatile Flow; Regional Blood Flow; Treatment Outcome; Vasodilation

2005
Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Fertility and sterility, 2005, Volume: 84, Issue:2

    Topics: Adult; Aged; Blood Coagulation Factors; Blood Glucose; Body Mass Index; Bone Density; Contraceptives, Oral, Synthetic; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Obesity; Overweight; Pharmaceutical Preparations; Postmenopause

2005
Molecular analysis of human endometrium: short-term tibolone signaling differs significantly from estrogen and estrogen + progestagen signaling.
    Journal of molecular medicine (Berlin, Germany), 2007, Volume: 85, Issue:5

    Topics: Cluster Analysis; Drug Therapy, Combination; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Gene Expression; Gene Expression Profiling; Gene Regulatory Networks; Humans; Hysterectomy, Vaginal; Medroxyprogesterone; Norpregnenes; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Postmenopause; Reproducibility of Results; RNA, Messenger; Sex Hormone-Binding Globulin; Signal Transduction; Uterine Prolapse

2007

Other Studies

3 other study(ies) available for tibolone and medroxyprogesterone

ArticleYear
A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:11

    Topics: Animals; Antineoplastic Agents, Hormonal; Apolipoproteins; Arteriosclerosis; Body Weight; Bone Density; Cholesterol, HDL; Coronary Disease; Estradiol; Estrogens; Estrone; Female; Horses; Lipoproteins; Macaca fascicularis; Medroxyprogesterone; Norpregnenes; Postmenopause; Progesterone Congeners

2001
Quality of life and psychological symptoms in Greek postmenopausal women: association with hormone therapy.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2006, Volume: 22, Issue:12

    Topics: Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Greece; Health Surveys; Humans; Life Style; Medroxyprogesterone; Mental Health; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Prospective Studies; Quality of Life; Social Behavior

2006
Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast.
    Maturitas, 2008, Dec-20, Volume: 61, Issue:4

    Topics: Animals; Breast; Disease Models, Animal; Drug Therapy, Combination; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Longitudinal Studies; Macaca fascicularis; Medroxyprogesterone; Norpregnenes; Ovariectomy; Receptors, Progesterone

2008